Epigenetic inactivation of ADAMTS9 via promoter methylation in multiple myeloma

Ling Peng1, Zesong Yang, Cui Tan

  • 1Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.

Insights

ADAMTS9 gene silencing by DNA methylation is prevalent in multiple myeloma (MM). Restoring ADAMTS9 expression suppressed MM cell growth, suggesting its potential as a tumor marker and therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • ADAMTS9 is a tumor suppressor gene often downregulated in cancers via promoter hypermethylation.
  • Multiple myeloma (MM) is a cancer of plasma cells with complex genetic alterations.
  • Understanding gene silencing mechanisms in MM is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the silencing mechanism of the ADAMTS9 gene in multiple myeloma (MM) cell lines.
  • To determine the role of DNA methylation in ADAMTS9 gene silencing in MM.
  • To evaluate the therapeutic potential of restoring ADAMTS9 expression in MM.

Main Methods:

  • Analysis of ADAMTS9 gene expression using RT-PCR in normal and MM samples.
  • Detection of ADAMTS9 promoter methylation using methylation-specific PCR.
  • Treatment of MM cells with DNA demethylating agents (5-aza-2'-deoxycytidine and trichostatin A).
  • Assessment of cell proliferation and colony formation after ectopic ADAMTS9 expression.

Main Results:

  • ADAMTS9 was highly expressed in normal samples and RPMI-8226 cells but silenced in KM3 cells and most MM patients.
  • Promoter methylation of ADAMTS9 was detected in KM3 cells and 66% of MM patients.
  • Demethylating agents restored ADAMTS9 expression in KM3 cells by suppressing promoter methylation.
  • Ectopic expression of ADAMTS9 significantly inhibited MM cell colony formation and proliferation.

Conclusions:

  • DNA methylation plays a critical role in ADAMTS9 gene silencing and the biological behavior of myeloma cells.
  • ADAMTS9 silencing by methylation may serve as a novel tumor marker for MM.
  • Demethylating agents show potential applicability in the treatment of MM.